Down-regulation of common NFκB-iNOS pathway by chronic Thalidomide treatment improves Hepatopulmonary Syndrome and Muscle Wasting in rats with Biliary Cirrhosis-Reference-Cited by-同舟云学术

Down-regulation of common NFκB-iNOS pathway by chronic Thalidomide treatment improves Hepatopulmonary Syndrome and Muscle Wasting in rats with Biliary Cirrhosis

Published:2016-12 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Li Tzu-Hao,Lee Pei-Chang,Lee Kuei-Chuan,Hsieh Yun-Cheng,Tsai Chang-Youh,Yang Ying-Ying,Huang Shiang-Fen,Tsai Tung-Hu,Hsieh Shie-Liang,Hou Ming-Chih,Lin Han-Chieh,Lee Shou-Dong

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep39405.pdf

Reference52 articles.

1. Fallon, M. B. et al. Impact of hepatopulmonary syndrome on quality of life and survival in liver transplant candidates. Gastroenterology 135, 1168–1175 (2008).

2. Nunes, H. et al. Role of nitric oxide in hepatopulmonary syndrome in cirrhotic Rats. Am J Respir Crit Care Med 164, 879–885 (2001).

3. Schenk, P. et al. Prognostic significance of the hepatopulmonary syndrome in patients with cirrhosis. Gastroenterology 125, 1042–1052 (2003).

4. Swanson, K. L., Wiesner, R. H. & Krowka, M. J. Natural history of hepatopulmonary syndrome: impact of liver transplantation. Hepatology 41, 1122–1129 (2005).

5. Zhang, J. et al. The role of CX3CL1/CX3CR1 in pulmonary angiogenesis and intravascular monocyte accumulation in rat experimental hepatopulmonary syndrome. J Hepatol 57, 752–758 (2012).

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathophysiological basis of hepatopulmonary syndrome;GASTROENTEROLOGY;2024-04-07

2. Therapeutic approaches for cholestatic liver diseases: the role of nitric oxide pathway;Naunyn-Schmiedeberg's Archives of Pharmacology;2023-09-22

3. MicroRNAs as novel biomarkers and potential therapeutic options for inflammatory cardiomyopathy;ESC Heart Failure;2023-09-07

4. Hepatopulmonary syndrome: a liver-induced oxygenation defect;Rare Diseases of the Respiratory System;2023-06-01

5. Association of resveratrol with the suppression of TNF-α/NF-kB/iNOS/HIF-1α axis-mediated fibrosis and systemic hypertension in thioacetamide-induced liver injury;Naunyn-Schmiedeberg's Archives of Pharmacology;2022-06-22